Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × neratinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 4 trastuzumab deruxtecan 3 pembrolizumab 3 Docetaxel 3 Cisplatin 3 Carboplatin 3 entrectinib 2 Platinum 2 Biopsy 2 Ado-Trastuzumab Emtansine 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 trastuzumab biosimilar HLX02 1 selinexor 1 sacituzumab govitecan 1 dehydroftorafur 1 ceralasertib 1 apalutamide 1 X-Rays 1 Trastuzumab 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pemetrexed 1 PF-05280014 1 Oral Hygiene 1 Ontruzant 1 Ogivri 1 Mitogen-Activated Protein Kinase Kinases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡